Drug regulator digitizes approval process for faster clearances
Drug regulator overhauls approval framework with digitisation, tech integration. The move aims to streamline drug and medical device clearances using digital systems and AI-driven tools. Faster approvals could benefit pharma firms with pending applications and reduce time-to-market. 📊 STOCKS: | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #regulatoryreform
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.